NASDAQ$ENSG

The Ensign Group Inc. · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Ensign Group reported record operating results, with GAAP diluted earnings per share of $0.82 and adjusted earnings per share of $0.80 for Q4 2020.

The Ensign Group reported record operating results for the fourth quarter of 2020, with GAAP diluted earnings per share of $0.82 and adjusted earnings per share of $0.80. The company saw improvements in patient volumes and skilled mix, and is confident in its ability to perform well despite the ongoing pandemic.

  • GAAP diluted earnings per share for the quarter was $0.82, representing an increase of 67.3% over the prior year quarter.
  • Adjusted diluted earnings per share for the quarter was $0.80, an increase of 33.3% over the prior year quarter.
  • Transitioning and skilled services revenue was $603 million for the quarter, an increase of 13.8% over the prior year quarter.
  • Real estate segment income was $8.7 million for the quarter, an increase of 73.5% from the prior year quarter.

Headline financials

Total Revenue

$629M

Previous: $560M+12.3%
EPS (adj)

$0.80

Previous: $0.60+33.3%
Net Income

$46.2M

Previous: $27.3M+68.9%
Operating Income

$55.9M

Previous: $39.7M+40.7%
Gross Profit

$103M

Previous: $85.3M+20.3%
Cash & Equivalents

$237M

Previous: $59.2M+299.8%
Total Assets

$2.55B

Previous: $2.36B+7.8%
Stock-Based Comp

$3.59M

Previous: $2.09M+71.8%

Revenue & EPS history

Ensign Group · Revenue · Quarterly

$629M

Q4 2020+12.3%vs Q4 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Ensign Group · $625M total across 1 segment · Q4 2020

  • Skilled Services
    $625M+17.9%

Forward guidance

Management reaffirmed its guidance for 2021, with annual earnings per share guidance of $3.44 to $3.56 per diluted share and annual revenue guidance of $2.62 billion to $2.69 billion.

Tailwinds

  • Positive impact of the vaccination efforts
  • Enormous upside in newly acquired operations
  • Opportunistic acquisitions on the horizon
  • Operations are primed to rebuild occupancies
  • Continue to gain additional market share as a result of the deepened relationships with acute care providers and other healthcare partners

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+1.7%

Avg return

Earnings day

+2.4%

Avg return

5 days after

+4.9%

Avg return

30 days after

55%

36 / 66 earnings

Positive

+21.1%

Q2 2020

Best reaction

-14.9%

Q4 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.2%-5.8%-10.2%
Q4 2025+13.8%+17.8%+19.7%
Q3 2025-0.1%-2.1%-3.2%
Q2 2025+0.1%+1.8%+1.2%
Q1 2025+0.7%+2.9%+14.9%
Q4 2024-8.7%-13.3%-12.4%
Q3 2024+1.9%+4.6%-2.4%
Q2 2024+4.5%+6.5%+8.4%
Q1 2024-1.5%-2.0%+2.4%
Q4 2023+6.7%+3.9%+7.7%
Q3 2023-1.4%-1.4%+13.3%
Q2 2023+1.4%+3.2%+7.0%
Q1 2023-5.7%-4.6%-13.1%
Q4 2022-1.7%-4.4%-2.7%
Q3 2022-1.9%+1.8%+6.7%
Q2 2022+9.5%+6.5%+7.0%
Q1 2022-1.4%-3.8%+1.1%
Q4 2021+7.9%+6.0%+15.9%
Q3 2021+8.3%+11.3%+10.6%
Q2 2021-2.5%-1.3%-3.8%
Q1 2021-3.3%-2.5%-6.3%
Q4 2020+0.4%-2.1%-6.3%
Q3 2020+2.8%+4.8%+23.2%
Q2 2020+21.1%+21.5%+20.9%
Q1 2020+2.6%+2.6%+22.6%
Q4 2019+11.6%+13.9%-2.5%
Q3 2019+1.1%+1.9%+3.9%
Q2 2019-10.3%-15.7%-17.2%
Q1 2019-1.0%+5.0%+4.2%
Q4 2018+11.3%+10.0%+10.2%
Q3 2018+11.2%+20.5%+21.1%
Q2 2018-2.7%-0.1%+8.4%
Q1 2018+12.4%+17.8%+30.7%
Q4 2017+7.5%+8.7%+20.1%
Q3 2017-0.8%-0.2%-2.9%
Q2 2017-7.4%-7.3%-4.4%
Q1 2017+10.4%+9.5%+2.4%
Q4 2016-14.9%-15.5%-8.9%
Q3 2016+3.4%+5.3%+20.7%
Q2 2016-12.2%-8.9%-12.6%
Q1 2016+1.1%
Q4 2015-5.6%
Q3 2015+13.0%
Q2 2015-0.8%
Q1 2015+5.7%
Q4 2014-6.0%
Q3 2014+5.3%
Q2 2014-1.9%
Q1 2014-2.0%
Q4 2013-1.0%
Q3 2013+3.5%
Q2 2013-3.9%
Q1 2013-5.3%
Q4 2012+3.1%
Q3 2012-5.1%
Q2 2012+2.6%
Q1 2011-0.7%
Q1 2012-0.7%
Q4 2011+7.7%
Q4 2009+7.7%
Q3 2011+12.7%
Q3 2010+12.7%
Q4 2010+1.2%
Q2 2010+1.2%
Q2 2011+1.2%
Q1 2010-3.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro